Table II.
Clinical characteristics of patients
| Risk factors | Asymptomatic |
P value | |
|---|---|---|---|
| Carotid stenosis (n = 63) | Controls (n = 41) | ||
|
| |||
| Age, years | 69.4 ± 7 | 65.5 ± 6.4 | .01 |
| Male sex | 98% | 95 | .56 |
| White race | 73 | 51 | .04 |
| Diabetes | 58 | 53 | .68 |
| Hypertension | 90 | 92 | .99 |
| Dyslipidemia | 73 | 71 | .99 |
| CADa | 67 | 38 | .01 |
| Peripheral vascular disease | 59 | 44 | .19 |
| Smoking | 76 | 74 | .82 |
| Antiplatelet treatment | 75 | 61 | .19 |
| Lipid-lowering treatmentb | 92 | 93 | .99 |
| Education, years | 12.2 ± 2.2 | 13.3 ± 1.8 | .01 |
| Stenosis side | |||
| Left | 41.3 | - | - |
| Right | 58.7 | - | - |
CAD, Coronary artery disease.
Categorical variables are presented as percentages.
Continuous variables are presented as mean ± standard deviation.
Boldface entries indicate values that are statistically significant (P < .05).
a
Coronary artery disease was defined as a positive history of myocardial infarction or angina.
b
Use of lipid-lowering medication was recorded only in those who were noted to have dyslipidemia.